CIK 0001509261 · Non-accelerated filer<br>Smaller reporting company
Rezolute, Inc.
Sign in to watch- Ticker
- RZLT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Jun 30
- Incorporated
- NV
- Entity type
- operating
- EIN
- 273440894
- Phone
- 650-206-4507
- Business address
- 275 SHORELINE DRIVE, SUITE 500, REDWOOD CITY, CA, 94065
- Former names
- AntriaBio, Inc., FITS MY STYLE INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-08-18 | Karnawat Sunil Ratilal Chief Commercial Officer | Grant or award | +25,000 | 27,442 | ||
| 2025-08-18 | Karnawat Sunil Ratilal Chief Commercial Officer | Grant or award · Employee Stock Option (Right to Buy) | +275,000 | 275,000 | ||
| 2025-06-25 | ROBERTS BRIAN KENNETH Chief Medical Officer | Purchase | +2,500 | $4.38 | $11K | 15,500 |
| 2025-06-24 | Evans Daron CFO | Purchase | +5,000 | $4.05 | $20K | 268,900 |
| 2025-06-13 | Kim Young-Jin Director | Purchase | +1,230,769 | $3.25 | $4.0M | 8,423,386 |
| 2025-06-13 | KREHER NERISSA Director | Purchase | +3,076 | $3.25 | $10K | 37,576 |
| 2025-06-10 | KREHER NERISSA Director | Grant or award | +9,000 | 34,500 | ||
| 2025-06-10 | KREHER NERISSA Director | Grant or award · Director Stock Options (Right to Buy) | +5,000 | 5,000 | ||
| 2025-06-10 | Labrucherie Gil M Director | Grant or award | +9,000 | 34,500 | ||
| 2025-06-10 | Labrucherie Gil M Director | Grant or award · Director Stock Option (Right to Buy) | +5,000 | 5,000 | ||
| 2025-06-10 | Hogenhuis Wladimir Director | Grant or award | +9,000 | 93,025 | ||
| 2025-06-10 | Hogenhuis Wladimir Director | Grant or award · Director Stock Option (Right to Buy) | +5,000 | 5,000 | ||
| 2025-06-10 | Kim Young-Jin Director | Grant or award | +9,000 | 149,950 | ||
| 2025-06-10 | Kim Young-Jin Director | Grant or award · Director Stock Option (Right to Buy) | +5,000 | 5,000 | ||
| 2025-06-10 | Evans Daron CFO | Grant or award | +26,000 | 263,900 | ||
| 2025-06-10 | Evans Daron CFO | Grant or award · Employee Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2025-06-10 | FAUCHET PHILIPPE Director | Grant or award | +9,000 | 34,500 | ||
| 2025-06-10 | FAUCHET PHILIPPE Director | Grant or award · Director Stock Option (Right to Buy) | +5,000 | 5,000 | ||
| 2025-06-10 | ROBERTS BRIAN KENNETH Chief Medical Officer | Grant or award | +26,000 | 157,352 | ||
| 2025-06-10 | ROBERTS BRIAN KENNETH Chief Medical Officer | Grant or award · Employee Stock Option (Right to Buy) | +15,000 | 15,000 |
Page 3 of 14 · 279 trades